What additional Arteris (AIP) share holdings does Charles Janac report?

Beyond the Bayview Legacy, LLC holdings, the filing shows 139,487 shares held directly by Charles Janac and 56,252 shares held indirectly through the Charles and Lydia Janac Trust , where he serves as trustee.

How is the sale by Bayview Legacy, LLC related to Charles Janac?

The filing explains that Charles Janac is the manager of Bayview Legacy, LLC and is therefore deemed to have voting and dispositive power over the shares beneficially owned by that entity.

Arteris (NASDAQ: AIP) CEO 10% owner sells 50,000 shares under trading plan

Q: Who is the insider in this Arteris, Inc. (AIP) Form 4 filing?

The insider is Charles K. Janac , who serves as President and CEO , a director , and a 10% owner of Arteris, Inc.

Q: How many Arteris (AIP) shares were sold in this transaction and at what price?

An entity managed by Charles Janac, Bayview Legacy, LLC , sold 50,000 shares of Arteris common stock at a weighted average price of $16.5831 per share, with individual sales between $16.2150 and $17.3600 .

Q: How many Arteris (AIP) shares does Bayview Legacy, LLC hold after the sale?

After the reported sale, Bayview Legacy, LLC beneficially owned 9,419,071 shares of Arteris common stock, over which Charles Janac is deemed to have voting and dispositive power.

Q: Does the Form 4 specify the price range for the Arteris (AIP) insider sale?

Yes. The reported $16.5831 price is a weighted average. The shares were sold in multiple transactions at prices ranging from $16.2150 to $17.3600 , and detailed trade data is available from the reporting person upon request.

Filing Impact

(Very High)

Filing Sentiment

(Negative)

Form Type

Rhea-AI Filing Summary

Arteris, Inc. (AIP) President and CEO Charles Janac, a director and 10% owner, reported an automatic sale of common stock made under a pre-arranged Rule 10b5-1 trading plan. On January 8, 2026, Bayview Legacy, LLC, an entity managed by Janac, sold 50,000 shares of Arteris common stock at a weighted average price of $16.5831 per share, with individual sale prices ranging from $16.2150 to $17.3600.

Following this transaction, 9,419,071 shares of Arteris common stock were beneficially owned indirectly through Bayview Legacy, LLC. Janac also held 139,487 shares directly and 56,252 shares indirectly through the Charles and Lydia Janac Trust, where he serves as trustee.

Insider Trade Summary

Net Seller: 50,000 shares ($829,155)

Net Sell 3 txns

Insider JANAC K CHARLES

Role President and CEO

Sold 50,000 shs ($829K)

Type	Security	Shares	Price	Value
Sale	Common Stock	50,000	$16.5831	$829K
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 9,419,071 shares (Indirect, Bayview Legacy, LLC); Common Stock — 139,487 shares (Direct)

Footnotes (1)

Transaction made pursuant to a 10b5-1 trading plan that was adopted by the Reporting Person on March 5, 2025. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $16.2150 to $17.3600 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The Reporting Person is the manager of Bayview Legacy, LLC and as such is deemed to have voting and dispositive power of the shares beneficially owned by Bayview Legacy, LLC. The shares are held by Charles and Lydia Janac Trust, for which the Reporting Person serves as trustee.

Form 4 Insider Transactions: What Each Field Means →

01/12/2026 - 04:50 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

JANAC K CHARLES

(Last)

(First)

(Middle)

C/O ARTERIS, INC.

900 E. HAMILTON AVE., SUITE 300

(Street)

CAMPBELL

95008

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
Arteris, Inc. [ AIP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
X	Officer (give title below)		Other (specify below)
	President and CEO

3. Date of Earliest Transaction (Month/Day/Year)
01/08/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	01/08/2026		S⁽¹⁾		50,000	D	$16.5831⁽²⁾	9,419,071	I	Bayview Legacy, LLC⁽³⁾
Common Stock								139,487	D
Common Stock								56,252	I	Charles and Lydia Janac Trust⁽⁴⁾

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Transaction made pursuant to a 10b5-1 trading plan that was adopted by the Reporting Person on March 5, 2025.

2. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $16.2150 to $17.3600 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

3. The Reporting Person is the manager of Bayview Legacy, LLC and as such is deemed to have voting and dispositive power of the shares beneficially owned by Bayview Legacy, LLC.

4. The shares are held by Charles and Lydia Janac Trust, for which the Reporting Person serves as trustee.

Remarks:

	/s/ Paul Alpern, as Attorney-in-Fact for JANAC K CHARLES	01/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

Who is the insider in this Arteris, Inc. (AIP) Form 4 filing?

The insider is Charles K. Janac, who serves as President and CEO, a director, and a 10% owner of Arteris, Inc.

How many Arteris (AIP) shares were sold in this transaction and at what price?

An entity managed by Charles Janac, Bayview Legacy, LLC, sold 50,000 shares of Arteris common stock at a weighted average price of $16.5831 per share, with individual sales between $16.2150 and $17.3600.

Was the Arteris (AIP) insider sale made under a 10b5-1 trading plan?

Yes. The filing states the transaction was made pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 5, 2025.

How many Arteris (AIP) shares does Bayview Legacy, LLC hold after the sale?

After the reported sale, Bayview Legacy, LLC beneficially owned 9,419,071 shares of Arteris common stock, over which Charles Janac is deemed to have voting and dispositive power.

Does the Form 4 specify the price range for the Arteris (AIP) insider sale?

Yes. The reported $16.5831 price is a weighted average. The shares were sold in multiple transactions at prices ranging from $16.2150 to $17.3600, and detailed trade data is available from the reporting person upon request.